Rising COPD and Asthma Cases Are Pushing the China Respiratory Drugs Market to New Heights
Chronic Obstructive Pulmonary Disease (COPD) and asthma remain two of the most common respiratory conditions in China. With millions of patients requiring continuous treatment, the demand for bronchodilators and anti-inflammatory medications continues to rise. Hospitals are reporting increasing outpatient visits linked to respiratory complications, especially during seasonal changes and...
0 ความคิดเห็น 0 แชร์ 367 ยอดวิว 0 รีวิว